| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 05/03/2007 | WO2006138568A3 Multivalent entrain-and-amplify immunotherapeutics for carcinoma |
| 05/03/2007 | WO2006138127A3 Botulinum toxin and the treatment of primary disorders of mood and affect |
| 05/03/2007 | WO2006132966A9 Webbed hiv envelope immunogens, methods for production and use of same |
| 05/03/2007 | WO2006113550A3 Viral nucleoprotein detection using an ion channel switch biosensor |
| 05/03/2007 | WO2006099875A8 Antibodies against cd38 for treatment of multiple myeloma |
| 05/03/2007 | WO2006096497A3 Vaccines comprising oligonucleotides having immunostimulatory sequences (iss) wherein the iss are conjugated to antigens and stabilized by buffer conditions and further excipients |
| 05/03/2007 | WO2006073496A3 Recombinant aav based vaccine methods |
| 05/03/2007 | WO2006067792A3 Aldolase autoantigens useful in diagnosis and treatment of alzheimer's disease |
| 05/03/2007 | WO2006055178A3 Anti-addl antibodies and uses thereof |
| 05/03/2007 | WO2006038208A3 Agents capable of downregulating an msf-a - dependent hif-1α and use thereof in cancer treatment |
| 05/03/2007 | WO2006017276A3 Recombinant rabies virus compositions |
| 05/03/2007 | WO2005092069A8 Chimeric infectious dna clones, chimeric porcine circoviruses and uses thereof |
| 05/03/2007 | WO2005086590A3 Muscle-relaxing proteins and uses thereof |
| 05/03/2007 | WO2005037989A3 Binding domain-immunoglobulin fusion proteins |
| 05/03/2007 | WO2004065575A3 Dna compositon and uses thereof |
| 05/03/2007 | WO2004018643A3 Method for regulating dopamine producing cells |
| 05/03/2007 | WO2003052049A3 Molecules for disease detection and treatment |
| 05/03/2007 | WO2002081649A3 ErbB INTERFACE PEPTIDOMIMETICS AND METHODS OF USE THEREOF |
| 05/03/2007 | US20070101451 LLG polypeptides of the triacylglycerol lipase family, and compositions and methods for their use in enzymatic hydrolysis, and protein and gene therapies |
| 05/03/2007 | US20070099832 Combination Therapy with p38 MAP Kinase Inhibitors and their Pharmaceutical Compositions |
| 05/03/2007 | US20070099255 Diagnostics and therapeutics for diseases associated with n-acetylated alpha-linked acidic dipeptidase 2(naaladase 2) |
| 05/03/2007 | US20070099253 Method for producing a specific antiserum against the universal tumorous antigen and method for diagnosing malignant tumours using said antiserum |
| 05/03/2007 | US20070099247 Polypeptide Display Libraries and Methods of Making and Using Thereof |
| 05/03/2007 | US20070099241 Method of detecting a subfraction of proBNP |
| 05/03/2007 | US20070099230 Novel nucleic acid sequences encoding melanoma associated antigen molecules, aminotransferase molecles, ATPase molecules, acyltransferase molecules, pyridoxal-phosphate dependant enzyme molecules and uses therefor |
| 05/03/2007 | US20070099183 Comparative ligand mapping from MHC positive cells |
| 05/03/2007 | US20070099181 isolation and characterization of new porcine circovirus (PCV) isolates from pigs displaying postweaning multisystemic wasting syndrome (PMWS). |
| 05/03/2007 | US20070099179 Method for inducing hepatitis c virus (hcv) replication in vitro, cells and cell lines enabling robust hcv replication and kit therefor |
| 05/03/2007 | US20070098807 Matrices for drug delivery and methods for making and using the same |
| 05/03/2007 | US20070098776 HLA class I A2 tumor associated antigen peptides and vaccine compositions |
| 05/03/2007 | US20070098745 Antagonistic properties of reef fish microflora |
| 05/03/2007 | US20070098744 Probiotic enterococci for improved immunity |
| 05/03/2007 | US20070098743 a mutant rhabdovirus having one or more mutation in a gene encoding a protein involved in blocking nuclear transport of mRNA or protein in an infected cells; capable of triggering the anti-viral systems of normal host cells; anticarcinogenic agent; vaccine adjuvant, vaccine vector |
| 05/03/2007 | US20070098742 For inducing an immune response to the influenza virus in canines, veterinary medicine |
| 05/03/2007 | US20070098741 Vectors derived from antibodies for transferring substances into cells |
| 05/03/2007 | US20070098740 Stabilisation of viral microparticles |
| 05/03/2007 | US20070098739 Vaccine compositions for vaccinating dogs against canine infectious respiratory disease |
| 05/03/2007 | US20070098738 MSP-3-like family of genes |
| 05/03/2007 | US20070098737 Streptococcal streptolysin S vaccines |
| 05/03/2007 | US20070098736 Injection vehicle for polymer-based formulations |
| 05/03/2007 | US20070098735 Methods for the Elimination of Pathogens and Other Particulate Agents |
| 05/03/2007 | US20070098734 loading antigen presenting cells from a subject; loading antigen presenting cells (APC's) having Class I MHC (major histocompatibility factor) molecules with T cell epitopes; culturing CD8+ T cells with APC's; expanding in culture; for allergic asthma, insulin dependent diabetes, arthritis |
| 05/03/2007 | US20070098733 In ovo delivery of an immunogen containing implant |
| 05/03/2007 | US20070098732 Immunologic compounds for prevention, protection, prophylaxis or treatment of immunological disorders, infections and cancer |
| 05/03/2007 | US20070098731 Treatment of infection due to clostridium difficile |
| 05/03/2007 | US20070098730 using a glycoconjugate comprising a dendrimeric or linear poly-Lysine enabling multiple epitopes to be covalently attached thereto; anticancer or antitumor agents |
| 05/03/2007 | US20070098729 Involves STEAP (six transmembrane epithelial antigen of the prostate); exposing cell to paclitaxel, androgen blocker, or immunomodudulator conjugated to antibody or fragment; drug delivery; diagnosis and therapy of prostate cancer, colon cancer, bladder cancer, ovarian cancer and pancreatic cancer; |
| 05/03/2007 | US20070098728 Novel compositions and methods in cancer |
| 05/03/2007 | US20070098727 Use of cytokine expression to predict skin inflammation; methods of treatment |
| 05/03/2007 | US20070098726 Methods of making and using antibodies directed to parathyroid hormone |
| 05/03/2007 | US20070098725 Antibody against fragments of apo-lipoprotein B; ischemic cardiovascular diseases |
| 05/03/2007 | US20070098724 Methods of Treatment Using Vascular Occlusion in Combination with One or More Therapies |
| 05/03/2007 | US20070098723 Peptide-based passive immunization therapy for treatment of atherosclerosis |
| 05/03/2007 | US20070098722 Medicament comprising inhibitors of long pentraxin ptx3 |
| 05/03/2007 | US20070098721 Amyloid beta(1-42) oligomers, derivatives thereof and antibodies thereto, methods of preparation thereof and use thereof |
| 05/03/2007 | US20070098720 Cd40-binding apc-activating molecules |
| 05/03/2007 | US20070098719 GITR binding molecules and uses therefor |
| 05/03/2007 | US20070098718 Methods of therapy for b cell-related cancers |
| 05/03/2007 | US20070098717 Methods of therapy for solid tumors expressing the cd40 cell-surface antigen |
| 05/03/2007 | US20070098716 immunomodulatory agents that potentiate the effect of TLR agonists; autoimmune disease |
| 05/03/2007 | US20070098715 Antibodies against the tenascin major antigens |
| 05/03/2007 | US20070098714 Preventive agent for vasculitis |
| 05/03/2007 | US20070098713 Nanoparticle delivery systems and methods of use thereof |
| 05/03/2007 | US20070098712 Method for making multispecific antibodies having heteromultimeric and common components |
| 05/03/2007 | US20070098711 produces anti-Staphylococcus antibodies; monoclonal antibody is produced by providing a population of B-lymphocytes from a donor, immortalizing the population, separating a plurality of cells from the population to yield a first oligoclonal cell culture, culturing the the cell culture; |
| 05/03/2007 | US20070098691 Binding site amino acid sequences for use as targeting agents in immunotherapeutics; antitumor agents; which conforms to human leukocyte antigen (HLA) motifs; immunogens; cytotoxic T lymphocytes; comprises proteases; prostate cancer |
| 05/03/2007 | US20070098688 Polymer conjugates of interferon beta-1a and uses |
| 05/03/2007 | US20070098683 antiproliferative agents; interleukins, immunoglobulins, colony stimulating factors |
| 05/03/2007 | US20070098634 method of inhibiting the growth; inhibiting neoplastic cell growth; cancer |
| 05/03/2007 | CA2665717A1 Methods and compositions comprising a flightless i antagonist for modulating wound repair |
| 05/03/2007 | CA2627463A1 Anti mineralocorticoid therapy of infection |
| 05/03/2007 | CA2627457A1 Botulinum neurotoxin a protein receptor and uses thereof |
| 05/03/2007 | CA2627376A1 Immunogenic compositions and methods of use |
| 05/03/2007 | CA2627309A1 Pseudomonas aeruginosa outer membrane protein pa5158 |
| 05/03/2007 | CA2627302A1 Compositions comprising yersinia pestis antigens |
| 05/03/2007 | CA2626783A1 Anti-addl monoclonal antibody and use thereof |
| 05/03/2007 | CA2626547A1 The induction of indoleamine 2,3-dioxygenase in dendritic cells by tlr ligands and uses thereof |
| 05/03/2007 | CA2626214A1 Novel use of il-1beta compounds |
| 05/03/2007 | CA2624221A1 Preventives/remedies for cancer |
| 05/02/2007 | EP1780285A1 Improved virus like particles (VLP) based on the small envelope protein of hepatitis B virus (HBsAg-S) |
| 05/02/2007 | EP1780276A1 Bone/joint disease sensitivity gene and use thereof |
| 05/02/2007 | EP1780273A1 Cell proliferation inhibitors containing anti-glypican 3 antibody |
| 05/02/2007 | EP1780268A2 PSCA: Prostate stem cell antigen and uses thereof |
| 05/02/2007 | EP1780221A1 Anti-synoviolin antibody |
| 05/02/2007 | EP1780220A1 Use of CEACAM8-specific substances for treating autoimmune diseases and a method for screening substances which induce apoptosis |
| 05/02/2007 | EP1780219A2 Protein S polypeptides and uses thereof |
| 05/02/2007 | EP1780217A1 Molecular structure of RHD negative locus |
| 05/02/2007 | EP1780216A1 Pantropic canine coronavirus |
| 05/02/2007 | EP1779866A1 Prime-boost vaccine for the protection of equines against viral infection |
| 05/02/2007 | EP1779865A1 Use of human growth hormone to stimulate mobilization of pluripotent hematopoietic stem cells |
| 05/02/2007 | EP1779863A1 Use of TGF-Beta and growth factors in the treatment and prevention of diseases of the intestinal mucosa |
| 05/02/2007 | EP1778880A2 Methods and reagents for diagnosing hantavirus infection |
| 05/02/2007 | EP1778879A2 Antibodies against west nile virus and therapeutic and prophylactic uses thereof |
| 05/02/2007 | EP1778875A2 Compositions and methods for the therapy and diagnosis of lung cancer |
| 05/02/2007 | EP1778871A2 Assays and methods using biomarkers |
| 05/02/2007 | EP1778727A1 Antibody specific for a chondroitin sulphate epitope |
| 05/02/2007 | EP1778726A2 Integrin antagonists with enhanced antibody dependent cell-mediated cytotoxicity activity |
| 05/02/2007 | EP1778723A2 Il-1 antagonist formulations |
| 05/02/2007 | EP1778291A2 Dimensional analysis of saccharide conjugates with gpc & sec-mals |
| 05/02/2007 | EP1778283A2 Vaccine compositions for treating coronavirus infection |